Brix et al., "Fluorodeoxyglucose
positron emission tomography and tumor marker expression in non-small cell lung cancer," Journal of Aoracic and Cardiovascular Surgery, vol.
positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose
positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
Biomarkers included fluorodeoxyglucose
positron emission tomography (FDG-PET), magnetic resonance imaging and measures of beta amyloid and tau found in cerebrospinal fluid (CSF).
Iannuzzi, "Results of 188 whole-body fluorodeoxyglucose
positron emission tomography scans in 137 patients with sarcoidosis," Chest, vol.
Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose
positron emission tomography.
In the meantime, clinicians are using PET in combination with the radiotracer fluorodeoxyglucose
(FDG) to distinguish Alzheimer's disease from frontotemporal dementia.
Mobile phones were placed on the left and right ears and brain imaging was performed with positron emission tomography (PET) with (18F) fluorodeoxyglucose
injection, used to measure brain glucose metabolism twice, once with the right cell phone activated (sound muted) for 50 minutes ('on' condition) and once with both cell phones deactivated ('off' condition).
In addition, the study found that using 18F-FDG-PET imaging (fluorodeoxyglucose
positron emission tomography) may provide a non-invasive way to monitor treatment response within a few days of starting treatment, prior to documented reductions in the tumour size.
Another technique uses PET scans to look for decreased uptake of fluorodeoxyglucose
(a radioactive glucose-like compound) in the temporal and parietal regions of the brain, an indication that brain cells are not absorbing glucose to fuel activity--also a marker for AD pathology.
True (A) or false (B)--click on the correct answer: Fluorodeoxyglucose
(FDG)-positron emission tomography (PET) is an accurate test in differentiating benign from malignant solitary pulmonary nodules.
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose
: use and limitations.